Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:1207-1213
doi: 10.1161/01.HYP.0000166721.42734.49
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Etzel, J. P.
Right arrow Articles by Insel, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Etzel, J. P.
Right arrow Articles by Insel, P. A.
Related Collections
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease
Right arrow Genomics

(Hypertension. 2005;45:1207.)
© 2005 American Heart Association, Inc.


Original Articles

Genetic Variation at the Human {alpha}2B-Adrenergic Receptor Locus

Role in Blood Pressure Variation and Yohimbine Response

Jason P. Etzel; Brinda K. Rana; Gen Wen; Robert J. Parmer; Nicholas J. Schork; Daniel T. O’Connor; Paul A. Insel

From the Departments of Medicine (G.W., R.J.P., D.T.O., P.A.I.), Pharmacology (J.P.E., P.A.I.), and Psychiatry (B.K.R., N.J.S.), and Polymorphism Research Laboratory (B.K.R., N.J.S.), University of California at San Diego; and the VA San Diego Healthcare System (D.T.O.), San Diego, Calif.

Correspondence to Paul A. Insel, MD or Daniel T. O’Connor, MD, Department of Pharmacology, 0636 9500 Gilman Drive, BSB 3076, La Jolla, CA 92093-0636. E-mail pinsel{at}ucsd.edu; doconnor@ucsd.edu

Exaggerated response to {alpha}2-adrenergic receptor ({alpha}2-AR) blockade by yohimbine in normotensive subjects is an intermediate phenotype that predicts increased risk for development of hypertension. Here, we assessed the 3 {alpha}2-AR loci ({alpha}2A, {alpha}2B, {alpha}2C) as candidate genes for their influence on baseline and yohimbine-mediated increase in mean arterial pressure. Because initial results with 173 individuals implicated a possible association of yohimbine response with genetic variation at a site in the {alpha}2B-AR gene, but not at sites in the other 2 {alpha}2-AR, we sequenced the {alpha}2B-AR gene (4.4 kb, including 1.2 kb upstream and 1.9 kb distal to the coding sequence) in those subjects and an additional 81 individuals to search for other {alpha}2B-AR variants. We identified 25 polymorphisms, of which 14 are previously unreported, and 2 major haplotypes that differ by the presence/absence of a 9-bp in-frame deletion that encodes Glu301 to Glu303. Frequency differences in haplotypes were observed between blacks and whites but did not predict response to yohimbine. Genotyping of 2 additional white cohorts, including 1269 individuals with extremes in blood pressure selected from >50 000 subjects, also failed to reveal an association of the 2 major {alpha}2B-AR haplotypes with differences in blood pressure. Thus, despite considerable polymorphism in {alpha}2-AR genes, such variation is not a major determinant of variability in yohimbine response and by inference, in susceptibility to essential hypertension.


Key Words: receptors, adrenergic alpha • haplotypes • SNP • intermediate phenotype




This article has been cited by other articles:


Home page
HypertensionHome page
P.-a. B. Shih and D. T. O'Connor
Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity
Hypertension, June 1, 2008; 51(6): 1456 - 1464.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. C. Duling, T. W. Cherng, J. R. Griego, M. F. Perrine, and N. L. Kanagy
Loss of {alpha}2B-adrenoceptors increases magnitude of hypertension following nitric oxide synthase inhibition
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2403 - H2408.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. S. Wolin
Loss of Vascular Regulation by Soluble Guanylate Cyclase Is Emerging as a Key Target of the Hypertensive Disease Process
Hypertension, June 1, 2005; 45(6): 1068 - 1069.
[Full Text] [PDF]